Navigation Links
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
Date:5/7/2008

-Eye who maintain vision at the end of one year, compared to ranibizumab patients. Visual acuity is defined as the total number of letters read correctly on the Early Treatment Diabetic Retinopathy Study (ETDRS) chart, a standard chart used in research to measure visual acuity. Maintenance of vision is defined as losing fewer than three lines (equivalent to 15 letters) on the ETDRS chart. Key secondary endpoints include the mean change from baseline in visual acuity as measured by ETDRS and the proportion of patients who gained at least 15 letters of vision at week 52.

Phase 2 Clinical Data

In a Phase 2 trial in 157 patients, announced in October 2007 at the Retina Society Conference in Boston, VEGF Trap-Eye met both primary and secondary key endpoints: a statistically significant reduction in retinal thickness (a measure of disease activity) after 12 weeks of treatment compared with baseline and a statistically significant improvement from baseline in visual acuity (ability to read letters on an eye chart).

Following the initial 12-week fixed-dosing phase of the trial, patients continued to receive therapy at the same dose on a PRN (as needed) dosing schedule based upon the physician assessment of the need for re-treatment in accordance with pre-specified criteria. At the 2008 meeting of the Association for Vision and Ophthalmology (ARVO), it was reported that, on average, patients on the PRN dosing schedule maintained the gain in visual acuity and decrease in retinal thickness achieved at week 12 through week 32 of the study.

About VEGF Trap-Eye

Vascular Endothelial Growth Factor (VEGF) is a naturally occurring protein in the body whose normal role is to trigger the formation of new blood vessels (angiogenesis) to support the growth of the body's tissues and organs. It has also been associated with the abnormal growth and fragility of new blood vessels in the eye, which lead to the development of wet AMD. VEGF Trap-Eye is a fully
'/>"/>

SOURCE Bayer HealthCare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
4. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
5. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Tainted Chinese Food Ingredients First Discovered in 2005
10. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... N.Y. , Aug. 22, 2014  Mark ... tomography (CT) imaging facility, is using the online ... and even 5D imaging to researchers and would-be ... launched, asks "What would YOU do if you ... possibility to researchers and explorers everywhere, from elementary ...
(Date:8/22/2014)... 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced ... of common stock and warrants at a price of ... prior to deducting underwriting discounts and commissions and offering ... are immediately separable and will be issued separately.  The ... on The NASDAQ Stock Market under the ticker symbol ...
(Date:8/21/2014)... Aug. 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ... today that it has completed integration with Nextech, ... Plastic Surgery and Dermatology practices. "Integration ... to healthcare practices using Nextech," stated Bob ... "Using information from the EMR we are able ...
Breaking Medicine Technology:Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4eRelevance Corporation Integrates with Nextech Electronic Medical Records 2
... 21, 2012 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH ... quarter ended December 31, 2011. Financial Results: ... ended December 31, 2011 were $28.4 million, as compared to ... 12 months ended December 31, 2011, total operating expenses were ...
... Link Platform:  BNVI.PK), a pharmaceutical company focused on the ... women,s health and cancer, today announced its decision to ... the Company has decided to delay the announcement of ... 2011, previously planned for today, to a later date.  ...
Cached Medicine Technology:Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update 2Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update 3Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update 4Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update 5Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update 6Bionovo Announces Decision to Explore Strategic Options and to Delay Announcement of Financial Results for 2011 2Bionovo Announces Decision to Explore Strategic Options and to Delay Announcement of Financial Results for 2011 3
(Date:8/22/2014)... Today, Zane Benefits, the #1 Online Health ... Plans. , According to Zane Benefits, employers are adopting ... the cost of healthcare without reducing coverage for employees. ... can be confusing. , The new guide contains a ... types of ABHPs. It also explains the similarities, ...
(Date:8/22/2014)... 22, 2014 MyWriters.com , an ... by marketing experts for marketers to help them drive ... the attention of Shane Michaels, prompting an investigative review. ... in any way knows that content is king when ... reports Michaels. “But even though content is extremely important, ...
(Date:8/22/2014)... Buying a policy for different life insurance ... about available coverage types by insurers in the U.S. The ... pricing to the public using its sortable tool at ... free and is expected to promote the discounts and special ... the U.S. The system is designed to help an adult ...
(Date:8/22/2014)... Worth, FL (PRWEB) August 22, 2014 Millennium ... of marijuana, resulting in a high level of drug use ... all ages fight against drug addiction and work to minimize ... highest levels of alcohol and drug addiction in history. According ... 2012, an estimated 23.9 million Americans aged 12 or older—or ...
(Date:8/22/2014)... By Amy Norton ... (HealthDay News) -- A growing number of Americans on ... a new study. Researchers found that between 2007 ... Security Disability Insurance benefits were prescribed narcotic painkillers each ... from 21 percent in 2007 to 23 percent in ...
Breaking Medicine News(10 mins):Health News:My Writers: Review Exposes Online Source for Quality Marketing Content 2Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4
... the Escorts hospital here will soon get a Rs.300 million ... ,"We will invest Rs.30 crore (Rs.300 million) in Escorts within ... Monday. ,"Due to Dr. Naresh Trehan's focus on ... focus for the last 20 months. With Naresh no more ...
... anxious about their fertility can feel a bit relaxed now. ... fertility screening test, called Fertell. The test has his ... is the first at-home device to measure the concentration of ... hormone considered a marker of egg quality. ,The ...
... pregnant women can cause disorders in their children, says ... behavioural problems which are part of fetal alcohol spectrum ... lives of the individual and those around them. A ... conditions are completely preventable by not drinking any alcohol ...
... Abuse and Mental Health Services Administration (SAMHSA) today ... million over three years to the state ... Intervention Project. The first year award is $400,000. ... to early intervention and treatment services for youth ...
... revealed that stress boosts the production of a brain ... on mice has now shown that blocking a different ... reported online in the Proceedings of the National Academy ... Medicine in St. Louis, is among the first studies ...
... The International Myeloma Foundation (IMF)-supporting research and providing ... families, researchers and physicians-today said that data from ... clinical trial shows the combination of DOXIL(R) with ... ,The follow-up study also showed no ...
Cached Medicine News:Health News:Fortis to Inject Rs.300 Mn into Escorts Hospital 2Health News:Fertility Test at Home Possible With a New Kit 2Health News:Pregnancy and Alcohol - a Dangerous Cocktail Warns BMA Scotland 2Health News:Iowa to Receive Grant Funding for Youth Suicide Prevention, Early Intervention 2Health News:Stress Protein Inactivation Cuts Alzheimer's Peptide in Mice 2Health News:Velcade(R) Plus Doxil(R) Improves Previously Treated Multiple Myeloma Patients 2
HME w/bacterial viral filter w/CO2...
Indications For Usage: ,Infant (recommended tidal volume 20-70ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended ...
... The Portex® Thermovent® T helps provide protection to ... is small and extremely lightweight making it ideal ... With a high rate of heat and moisture ... retention., ,All HMEs and filters have ISO ...
... The Portex® Thermovent® T helps provide protection to ... is small and extremely lightweight making it ideal ... With a high rate of heat and moisture ... retention., ,All HMEs and filters have ISO ...
Medicine Products: